Mankind Pharma's Stock Price Rises by 3.35% and Outperforms Sector in Today's Trading Session
Mankind Pharma, a leading pharmaceutical company in India, saw a 3.35% increase in its stock price on October 9th, 2024. The stock has been given a 'Hold' call by MarketsMojo and is currently trading close to its 52-week high. It has also outperformed the sector by 1.51% in today's trading session, showcasing its strong performance in the market.
Mankind Pharma, a leading pharmaceutical company in India, has seen a rise in its stock price by 3.35% on October 9th, 2024. The stock has been given a 'Hold' call by MarketsMOJO, a leading stock market analysis platform.
The stock is currently trading close to its 52-week high, with only a 3.68% difference. It has also outperformed the sector by 1.51% in today's trading session. This marks the second consecutive day of gains for Mankind Pharma, with a 4.8% increase in its stock price.
Intraday, the stock reached a high of Rs 2683.15, showing a 3.42% increase. Mankind Pharma is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its stock price.
The pharmaceutical and drugs sector has also seen a 2.03% increase, further highlighting the positive sentiment in the industry.
In comparison to the overall market performance, Mankind Pharma has outperformed the Sensex by 3.16% in the last 1 day and 11.01% in the last 1 month. This showcases the strong performance of the company in the current market conditions.
With its consistent growth and positive performance, Mankind Pharma continues to be a strong player in the pharmaceutical industry. Investors can keep a close eye on the stock for potential opportunities.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
